AJP - Renal Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 278: F940-F948, 2000;
0363-6127/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vågnes, O.
Right arrow Articles by Arendshorst, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vågnes, O.
Right arrow Articles by Arendshorst, W. J.
Vol. 278, Issue 6, F940-F948, June 2000

Upregulation of V1 receptors in renal resistance vessels of rats developing genetic hypertension

Øyvind Vågnes1, Jian J. Feng2, Bjarne M. Iversen1, and William J. Arendshorst2

1 Renal Research Group, Institute of Medicine, University of Bergen, Bergen, Norway; and 2 Department of Cell and Molecular Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7545

Previous studies have demonstrated that arginine vasopressin (AVP) produces exaggerated renal vasoconstriction in young spontaneously hypertensive rats (SHR) relative to normotensive rats. The exaggerated renal vascular reactivity does not appear to be due to a primary defect in postreceptor calcium signal transduction. Although the magnitudes of vascular responses differ, the relative proportions of calcium entry and mobilization pathways evoked by AVP in renal resistance vessels are similar in these rat strains. The purpose of the present study was to evaluate possible differences in V1 mRNA and receptor density and affinity in preglomerular resistance vessels (<50 µm) obtained from young Wistar-Kyoto (WKY) and SHR. Quantitative RT-PCR analysis revealed twofold greater expression of the V1a receptor gene in preglomerular arterioles of 7-wk-old SHR compared with WKY. In vitro radiolabeled ligand binding studies were performed under equilibrium conditions on preglomerular resistance arterioles freshly isolated from kidneys of 7-wk-old rats. The results indicate that AVP receptor density (Bmax) is two to three times greater in SHR than in WKY (248 ± 24 vs. 91 ± 11 fmol/mg protein, P < 0.001). The affinity does not differ between strains (Kd = 0.5 nM). Displacement studies yielded similar results for SHR and WKY. Unlabeled AVP completely displaced [3H]AVP binding, with an IC50 of 2.5 × 10-10 M. Expression of AVP receptor types in afferent arterioles was evaluated using the V1 receptor agonist, [Phe2, Ile3,Org8]vasopressin, the V1 receptor antagonist, [d(CH2)5, Tyr(Me)2,Tyr(NH2)9]Arg8-vasopressin, and the V2 receptor agonist, desamino-[D-Arg8]vasopressin. Both the V1 agonist and antagonist displaced up to 90% of the AVP binding with IC50 values of 4 × 10-8 and 8 × 10-7 M, respectively. The V2 receptor agonist was a weak inhibitor, displacing less than 15% of AVP binding at a high concentration of 10-4 M. These results demonstrate that virtually all AVP receptors in the preglomerular arterioles are of the V1 type. Collectively, our results provide evidence that the enhanced renal reactivity to AVP is mediated by a higher density of V1 receptors associated with increased gene expression in renal resistance vessels of SHR developing genetic hypertension.

renal circulation; vascular resistance; afferent arteriole; glomerulus; vasopressin; spontaneously hypertensive rat; Wistar-Kyoto rat


This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Hultstrom, F. Helle, and B. M. Iversen
AT1 receptor activation regulates the mRNA expression of CAT1, CAT2, arginase-1, and DDAH2 in preglomerular vessels from angiotensin II hypertensive rats
Am J Physiol Renal Physiol, July 1, 2009; 297(1): F163 - F168.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. Helle, M. Hultstrom, T. Skogstrand, F. Palm, and B. M. Iversen
Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C
Am J Physiol Renal Physiol, January 1, 2009; 296(1): F78 - F86.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst
Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, F. H. Hansen, J. J. Feng, B. M. Iversen, and W. J. Arendshorst
Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states
Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1249 - F1256.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
F. H. Hansen, O. B. Vagnes, and B. M. Iversen
Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat
Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1023 - F1031.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, F. H. Hansen, R. E. F. Christiansen, C. Gjerstad, and B. M. Iversen
Age-dependent regulation of vasopressin V1a receptors in preglomerular vessels from the spontaneously hypertensive rat
Am J Physiol Renal Physiol, May 1, 2004; 286(5): F997 - F1003.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online